On 10/1/25, Biogen Inc (NASDAQ: BIIB) stock enjoyed a major increase of 10.1%, closing at $154.22. Moreover, trading volume in this advance was exceptionally high at 250% of normal. Relative to the market the stock has been weak over the last nine months but has risen 10.7% during the last week.
Current PriceTarget Research Rating
Biogen has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Biogen has a good Appreciation Score of 84 but a poor Power Rating of 29, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment